1.68
3.45%
-0.06
Vorhandelsmarkt:
1.68
Finanzdaten der Predictive Oncology Inc-Aktie (POAI)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 |
Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
Revenues |
45.90%
0.7151
|
0.4901 | 0.2399 | 0.3635 | 0.4558 |
Cost Of Revenue |
33.06%
0.1069
|
0.1598 | 0.1201 | 0.1534 | 0.1082 |
Gross Profit |
84.08%
0.6081
|
0.3303 | 0.1198 | 0.21 | 0.3477 |
Operating Expenses
|
12.29%
3.7622
|
4.2896 | 3.5847 | 8.1735 | 4.4784 |
Benefits Costs and Expenses |
-
|
- | - | 27.24 | - |
Costs And Expenses |
13.04%
3.8691
|
4.4493 | 3.7049 | 8.0309 | 4.5866 |
Operating Income/Loss |
20.34%
-3.1541
|
-3.9592 | -3.465 | -7.9634 | -4.1307 |
Income/Loss From Continuing Operations Before Tax |
118.23%
0.7151
|
-3.9234 | -3.4218 | -26.88 | 0.4558 |
Income Tax Expense/Benefit |
-
|
- | - | - | - |
Income/Loss From Continuing Operations After Tax |
19.37%
-3.1635
|
-3.9234 | -3.4218 | -7.9161 | -4.0595 |
Net Income/Loss
|
19.37%
-3.1635
|
-3.9234 | -3.4218 | -7.9161 | -4.0595 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
0.87%
4.0314
|
3.9965 | 3.9681 | 1.9135 | 78.38 |
Diluted Average Shares |
0.87%
4.0314
|
3.9965 | 3.9681 | 1.9135 | 78.38 |
Basic Earnings Per Share |
20.41%
-0.78
|
-0.98 | -0.86 | -0.10 | -0.05 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
Kapitalisierung:
|
Volumen (24h):